Clinical Features and Prognosis of Adult-onset Still's Disease: 61 Cases from China

被引:91
作者
Zeng, Ting [1 ]
Zou, Yu-Qiong [1 ]
Wu, Mei-Fang [1 ]
Yang, Cheng-De [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Rheumatol, Shanghai 200001, Peoples R China
基金
中国国家自然科学基金;
关键词
ADULT-ONSET STILL'S DISEASE; REFRACTORY; PROGNOSIS; CLASSIFICATION; MANAGEMENT; CRITERIA; MANIFESTATIONS; PATHOGENESIS; LEFLUNOMIDE; COMBINATION; MULTICENTER; EXPERIENCE; ANAKINRA;
D O I
10.3899/jrheum.080365
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To describe the onset, clinical features, prognostic factors, and treatment of adult-onset Still's disease (AOSD) in cases from China. Methods. Sixty-one Chinese patients with AOSD were analyzed retrospectively. Results. Common clinical features were fever (100.0%), rash (88.5%), and arthritis (82.0%). The laboratory findings were as follows: leukocytosis (83.6%), increased erythrocyte sedimentation rate (100.0%), elevated transaminase concentrations (23.0%), elevated ferritin levels (79.6%), negative antinuclear antibody (88.5%), and negative rheumatoid factor (88.5%). Of the 61 patients, 44.3% exhibited a monocyclic disease pattern, 29.5% experienced disease relapse at least once, 16.4% exhibited chronic articular course, and 9.8% died; most deaths were due to pulmonary infection and respiratory failure. Based on the disease course, we divided the 61 patients into 2 groups: those with favorable outcome (cyclic disease course, n = 45) and unfavorable outcome (chronic disease course or death, n = 16). We analyzed the prognostic factors for the 2 groups, and found that pleuritis, interstitial pneumonia, elevated ferritin levels, and failure of fever to subside after 3 days of prednisolone at 1 mg/kg/day were unfavorable prognostic factors for patients. with AOSD. Conclusion. Patients with AOSD had complex symptoms with no specific laboratory findings. Our results indicate that AOSD is not a relatively benign disease, especially in cases that are refractory to high doses of prednisone. (First Release March 1 2009; J Rheumatol 2009:36:1026-31; doi: 10.3899/jrheum.080365)
引用
收藏
页码:1026 / 1031
页数:6
相关论文
共 36 条
[1]   Successful treatment of refractory adult onset Still's disease with rituximab [J].
Ahmadi-Simab, K. ;
Lamprecht, P. ;
Jankowiak, C. ;
Gross, W. L. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (08) :1117-1118
[2]   Long-term follow-up of patients with adult-onset Still's disease [J].
Akritidis, N. ;
Papadopoulos, A. ;
Pappas, G. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (05) :395-397
[3]   Adult-onset Still's disease in Saudi Arabia [J].
Al-Arfaj, AS ;
Al-Saleh, S .
CLINICAL RHEUMATOLOGY, 2001, 20 (03) :197-200
[4]   Adult onset Still's disease:: review of 26 cases [J].
Alonso, Elena Riera ;
Marques, Alejandro Olive ;
Lizarzaburu, Meritxell Salles ;
Perez, Susana Holgado ;
Casares, Elisabet Garcia ;
Marsa, Xavier Tena .
MEDICINA CLINICA, 2007, 129 (07) :258-261
[5]   Adult-onset still disease in southeast Brazil [J].
Appenzeller, S ;
Castro, GRW ;
Costallat, LT ;
Samara, AM ;
Bértolo, MB .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2005, 11 (02) :76-80
[6]   STILL,S DISEASE IN ADULT [J].
BYWATERS, EG .
ANNALS OF THE RHEUMATIC DISEASES, 1971, 30 (02) :121-+
[7]   COMPARISON OF LONG-TERM EVOLUTION OF ADULT ONSET AND JUVENILE ONSET STILL DISEASE, BOTH FOLLOWED UP FOR MORE THAN 10 YEARS [J].
CABANE, J ;
MICHON, A ;
ZIZA, JM ;
BOURGEOIS, P ;
BLETRY, O ;
GODEAU, P ;
KAHN, MF .
ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (05) :283-285
[8]   Leflunomide and azathioprine combination in refractory Adult-onset Still's disease [J].
Cefle, A .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (04) :764-767
[9]   ADULT-ONSET STILLS DISEASE - CLINICAL COURSE AND OUTCOME [J].
CUSH, JJ ;
MEDSGER, TA ;
CHRISTY, WC ;
HERBERT, DC ;
COOPERSTEIN, LA .
ARTHRITIS AND RHEUMATISM, 1987, 30 (02) :186-194
[10]   Diagnosis and management of adult onset Still's disease [J].
Efthimiou, P ;
Paik, PK ;
Bielory, L .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (05) :564-572